Clinical features and outcomes in patients with secondary Ewing sarcoma. Read more about Clinical features and outcomes in patients with secondary Ewing sarcoma.
The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma. Read more about The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma.
Clinical features and outcomes in patients with Ewing sarcoma and regional lymph node involvement. Read more about Clinical features and outcomes in patients with Ewing sarcoma and regional lymph node involvement.
Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma. Read more about Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma.
Myelosuppression and infectious complications in children with Down syndrome and acute lymphoblastic leukemia. Read more about Myelosuppression and infectious complications in children with Down syndrome and acute lymphoblastic leukemia.
Absolute lymphocyte counts refine minimal residual disease-based risk stratification in childhood acute lymphoblastic leukemia. Read more about Absolute lymphocyte counts refine minimal residual disease-based risk stratification in childhood acute lymphoblastic leukemia.
Prevention of bacterial infection in pediatric oncology: what do we know, what can we learn? Read more about Prevention of bacterial infection in pediatric oncology: what do we know, what can we learn?
Epidemiology and potential preventative measures for viral infections in children with malignancy and those undergoing hematopoietic cell transplantation. Read more about Epidemiology and potential preventative measures for viral infections in children with malignancy and those undergoing hematopoietic cell transplantation.
Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data. Read more about Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.
Evaluation of polymorphisms in EWSR1 and risk of Ewing sarcoma: a report from the Childhood Cancer Survivor Study. Read more about Evaluation of polymorphisms in EWSR1 and risk of Ewing sarcoma: a report from the Childhood Cancer Survivor Study.
